SCAMMERS OFTEN TARGET OLDER CONSUMERS. AND ACCORDING TO THE LATEST SCAM REPORT FROM THE FEDERAL TRADE COMMISSION, SCAMMERS ...
Don’t offer Devin Roche warm bread with butter and jam. If he’s around, don’t raise a glass and wish the bride and groom well ...
When the Monarchs (9-3) take on South Florida in Wednesday’s StaffDNA Cure Bowl at Orlando’s Camping World Stadium, they’ll ...
The Kent State women's basketball team rewrote the record book with a 117-37 victory during the annual Education Day ...
Roche received expanded approval from the Food and Drug Administration for a test to diagnose breast cancer. The pharmaceutical company said Monday that the FDA approved the PATHWAY HER2 (4B5) test ...
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's Enhertu in combination with Roche's drug, Perjeta, for the first-line treatment of patients with a type of ...
The U.S. Food and Drug Administration has approved Daiichi Sankyo's therapy in combination with Roche's drug for the ...
“This process can be likened to a bottle of sparkling water containing dissolved volatiles that exolve when the bottle is ...
Top Five Articles on 360Dx Last Week: Roche Vaginitis Test; FDA Reclassification of CDx Assays; More
Last week, readers were most interested in a story about a PCR test from Roche for vaginitis getting CE marking.
Ascendis Pharma's Yorvipath and Skytrofa drove Q3 revenues to €213.6 million, nearly quadrupling year-over-year. Read why ...
In the midst of regulatory and political upheaval, biopharma’s R&D engine kept running, churning out highs and lows in equal ...
Roche revealed in its first-quarter results statement that giredestrant missed the mark in the phase 2 acelERA trial in advanced breast cancer, in what appears to be another blow to the emerging oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback